We are now FDA-inspected!
A PAI inspection on our leflunomide API was conducted by US FDA on October 25-28, and GMP compliance was found to be acceptable.
 
We thank those who visited our booth during CPhI 2004, Brussels, and look forward to seeing you again soon. Please do not hesitate to bother us with your needs.
   
Benzonatate, Calcipotriol, Flupentixol, Melitracen, and Mycophenolate mofetil have recently been successfully commercialized.
 
 
 
 
 
 
 
 
Copyrights©2002 All rights Formosa Laboratories,Inc.